Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Daisuke Kobayashi Last modified date:2021.06.25

Lecturer / Department of clinical pharmacy / Department of Pharmaceutical Health Care and Sciences / Faculty of Pharmaceutical Sciences


Papers
1. Kawashiri T, Kobayashi D, Egashira N, Tsuchiya T, Shimazoe T., Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents., Sci Rep., 10, 1, 12665, 2020.01.
2. Shigematsu N*, Kawashiri T*, Kobayashi D, Shimizu S, Mine K, Hiromoto S, Uchida M, Egashira N, Shimazoe T. (*equal contribution), Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro, Sci Rep., 1, 10, 6734, 2020.04.
3. Kawashiri T, Tokunaga A, Kobayashi D, Shimazoe T., Anti-tumor activities of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and bisphosphonates in pancreatic cell lines which show poor responses to gemcitabine. , Biol Pharm Bull., 1, 43, 49-52, 2020.01.
4. Kawashiri T, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T, Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect, J. Pharmacol. Sci., 3, 140, 291-294, 2019.07.
5. Tsuchiya Y, Suetsugu K, Yamamoto N, Kobayashi D, Tsuji T, Watanabe H, Egashira N, Masuda S., Simultaneous determination of plasma concentration of 12 oral molecular-targeted drugs by ultra-performance liquid chromotography-tandem mass spectrometry, The Japanese Journal of Therapeutic Drug Monitoring, 36, 3, 105-116, 2019.09.
6. Epp D, Kubota T, Yoshida M, Kishimoto J, Kobayashi D, Shimazoe T., Promoting Patient Care Through Communication Training in a Preclerkship Pharmacy Education Course in Japan, Am J Pharm Educ., 83, 5, 814-823, 2019.06.
7. Miyagi A*, Kawashiri T*, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T (*equal contribution), Dimethyl fumarate attenuates oxaliplatin-induced peripheral neuropathy without affecting the anti-tumor activity of oxaliplatin in rodents, BIOLOGICAL AND PHARMACEUTICAL BULLETIN, 42, 4, 638-644, 2019.04.
8. Kawashiri T, Miyagi A, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T., Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro., J Pharmacol Sci., 137, 2, 202-211, 2018.06.
9. Takechi T, Hirota T, Sakai T, Maeda N, Kobayashi D, Ieiri I., Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene., Drug Metab Dispos., 46, 5, 628-635, 2018.05.
10. Murakami A, Kobayashi D, Kubota T, Zukeyama N, Mukae H, Furusyo N, Kainuma M, Shimazoe T., Bioelectrical impedance Analysis (BIA) of the association of the Japanese Kampo concept "Suidoku" (fluid disturbance) and the body composition of women., BMC Complement Altern Med., 16, 1, 405, 2016.10.
11. Murakami A, Kubota T, Kobayashi D, Sumoto Y, Furusyo N, Ando S, Kainuma M, Shimazoe T., Heart rate variability as a predictor of the outcome of treatment with kampo medicines that include Bupleuri Radix (Saiko)., Res Rev Pharm Pharm Sci., 5, 4, 1-8, 2016.10.
12. Yamada T, Kubota T, Yonezawa M, Nishio H, Kanno S, Yano T, Kobayashi D, Egashira N, Takada H, Hara T, Masuda S., Evaluation of teicoplanin trough values after the recommended loading dose in children with associated safety analysis., Pediatr Infect Dis J., 36, 4, 398-400, 2017.04.
13. Effect of Medical Educational Lectures by Pharmacists for Understanding and Relieving Post-laryngectomy Symptoms..
14. Saito J, Hirota T, Furuta S, Kobayashi D, Takane H, Ieiri i, Association between DNA Methylation in the miR-328 5 '-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta, PLOS ONE, 10.1371/journal.pone.0072906, 8, 8, 2013.08.
15. Sasaki T, Hirota T, Ryokai Y, Kobayashi D, Kimura M, Irie S, Higuchi S, Ieiri I., Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.

, Drug Metab Pharmacokinet., published online; April 22, 2011., 2011.04.
16. Murata Y, Kobayashi D, Imuta N, Haraguchi K, Ieiri I, Nishimura R, Koyama S, Mine K., Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome., J Clin Psychopharmacol., 30, 1, 11-7, 2010.02.
17. Tanaka M, Kobayashi D, Murakami Y, Ozaki N, Suzuki T, Iwata N, Haraguchi K, Ieiri I, Kinukawa N, Hosoi M, Ohtani H, Sawada Y, Mine K. , Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea., Int J Neuropsychopharmacol., 11(2):261-7., 2008.03.
18. Murata Y, Murakami Y, Kobayashi D, Kubo C, Mine K, The efficacy of combination therapy with paroxetine and tandospirone for depressive and anxiety disorders, International Clinical Psychopharmacology, Vol 21(4) A14, 2006.07.
19. Tanaka M, Kobayashi D, Murakami Y, Suzuki T, Iwata N, Ozaki N, Haraguchi K, Ieiri I, Hosoi M, Sawada Y, Kubo C, Kine K, The relationship between the polymorphism in the 5-HT3B receptor gene and nausea induced by paroxetine in Japanese patients, International Clinical Psychopharmacology, Vol 21(4) A12, 2006.07.
20. Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, Suzuki H, Nanba E, Oshimura M, Terakawa N, Otsubo K, Mine K, Sugiyama Y, Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta, Drug Metab Dispos, 10.1124/dmd.104.001628, 33, 1, 94-101, 2005; 33(1):94-101, 2005.01.
21. Murakami Y, Kobayashi D, Suzuki T, Iwata N, Ozaki N, Haraguchi K, Ieiri I, Hosoi M, Sawada Y, KuboC, Mine K, Studies on the adverse effects of paroxetine in Japanese patients: correlation with genetic polymorphisms in CYP2D6 and serotonin related genes, International Clinical Psychopharmacology, 10.1097/00004850-200505000-00037, 20, 3, A9-A9, 2005; 20(3):A9, 2005.05.
22. Hirota T, Kobayashi D, Takane H, Higuchi S, Otsubo K, Ieiri I, Allelic variations in the drug transporter genes, DRUG METABOLISM REVIEWS, 36, 121-121, 36:121-121 243 Suppl. 1, 2004.08.
23. Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, Kobayashi D, Ieiri I, Mine K, Ohtsubo K, Sugiyama Y, Functional analysis of SNPs variants of BCRP/ABCG2, Pharm Res, 10.1023/B:PHAM.0000045245.21637.d4, 21, 10, 1895-1903, 2004; 21(10):1895-903, 2004.10.
24. Takane H, Kobayashi D, Hirota T, Kigawa J, Terakawa N, Otsubo K, Ieiri I, Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene, J Pharmacol Exp Ther, 10.1124/jpet.104.069724, 311, 3, 1179-1187, 2004; 311(3):1179-87, 2004.12.
25. Nishitsuji K, To H, Murakami Y, Kodama K, Kobayashi D, Yamada T, Kubo C, Mine K, Tandospirone in the Treatment of Generalised Anxiety Disorder and Mixed Anxiety-Depression Results of a Comparatively High Dosage Trial, Clin Drug Invest, 10.2165/00044011-200424020-00007, 24, 2, 121-126, 2004; 24(2):121-126, 2004.01.
26. Yuki Tomiyoshi, Daisuke Kobayashi, Ichiro Ieiri, Kazutaka Shimoda, Hisakazu Ohtani, Shun Higuchi, Yasufumi Sawada, Chiharu Kubo, Kazunori Mine, The effects of CYP2D6 and CYP2C19 genotypes on clinical response and side effects of clomipramine in Jaapanese patients, International Clinical Psychopharmacology, 10.1097/00004850-200305000-00043, 18, 3, 188-189, 2003; 18(3):188-189, 2003.01.